Risk of hallucinations and amantadine treatment in levodopa-induced dyskinesia patients with Parkinson’s disease: a meta-analysis of randomized controlled trials
Objective: The present meta-analysis aims to find out association between risk of hallucinations and amantadine treatment in levodopa-induced dyskinesia (LID) patients with Parkinson’s disease (PD).…Incidence of childhood trauma in patients with functional movement disorder and its impact on motor symptoms severity
Objective: To assess the impact of self-reported childhood traumatic experience on motor symptoms severity in a group of patients with functional movement disorder (FMD). Background:…Is an integrated Parkinson’s Dementia Service the way forward?
Objective: To illustrate the role of a single team in managing all facets of Parkinson’s Background: The Cardiff and Vale Parkinson’s service is an integrated,…Basal ganglia shape in de novo Parkinson’s disease patients can predict the onset of Levodopa Induced Dyskinesias
Objective: In the current study, we aimed to examine structural MRI data from a large sample of de novo PD patients and to identify potential…Next-generation sequencing analysis of circulating microRNAs in multiple system atrophy
Objective: The discriminatory peripheral circulating small non-coding RNAs (sncRNAs) using next-generation sequencing (NGS) between patients of multiple system atrophy (MSA), Parkinson's disease (PD), and healthy controls…Predictors of death in Parkinson’s disease
Objective: To investigate how clinical, motor and behavioural characteristics impact on Parkinson mortality in a cohort from a tertiary movement disorders specialty center . Background:…Distinct striatal connectivity patterns in patients with Parkinson’s disease with and without urinary symptoms
Objective: To investigate the potential effect of urinary symptoms on the regional striatal functional connectivity (FC) in a cohort of drug-naïve PD patients applying a…Experience of Quality of Life in German Persons living with Parkinson’s Disease: A Qualitative Exploration
Objective: It seems essential to understand how people with Parkinson´s disease (PwPD) experience quality of life (QoL) and to which domains they assign particular importance.…Is a Parkinson’s Sialorrhoea service effective?
Objective: Evaluate the efficacy and tolerance of Botulinum Toxin A (BoNT A) in managing sialorrhoea in People with Parkinsons (PwP)Assess impact on quality of life…Longitudinal CSF measurements of alpha-synuclein, amyloid beta and tau in Parkinson disease
Objective: To evaluate whether cerebrospinal fluid (CSF) levels of alpha synuclein (Asyn), amyloid beta (Aβ) and tau change with disease progression and to evaluate whether…
- « Previous Page
- 1
- …
- 434
- 435
- 436
- 437
- 438
- …
- 1734
- Next Page »